1-6 of 6
Xiaoyun Zheng
Close
Sort by
Journal Articles

CEOP/IVE/GDP Alternating Regimen Compared with CEOP As the First-Line Therapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma: Results from a Phase 2, Multi-Center, Randomized, Controlled Clinical Trial

Mingci Cai, MD, Shu Cheng, MD PhD, Wang Xin, PhD, Jianda Hu, PhD, Yongping Song, Zixun Yan, Yujie Jiang, MD, Xiaosheng Fang, PhD, Xiaoyun Zheng, Lihua Dong, Mengmeng Ji, Li Wang, MD PhD, Pengpeng Xu, Weili Zhao
Journal: Blood
Blood (2019) 134 (Supplement_1): 1556.
https://doi.org/10.1182/blood-2019-122369
Published: 2019
Journal Articles

DA-Edoch Regimen As First-Line Treatment Could Significantly Improve the Early Efficacy of Adult T-Cell Leukemia/Lymphoma

Jianda Hu, Prof.Dr., Zhengjun Wu, Xiaoyun Zheng, Jing Li, Tingbo Liu, Prof.Dr., Ting Yang
Journal: Blood
Blood (2018) 132 (Supplement 1): 5208.
https://doi.org/10.1182/blood-2018-99-119008
Published: 2018
Journal Articles

Intensive Chemotherapy with DA-Edoch Followed By Allogeneic Hematopoietic Stem Cell Transplantation Improved the Outcome in HTLV-1 Associated Adult T Cell Leukemia (ATL)

Jianda Hu, MD PhD, Ting Yang, Prof.,MD,PhD, Zhengjun Wu, MD, Jinghua Ren, MD, Xiaoyun Zheng, MD, Tingbo Liu, Prof.,MD,PhD, Zhizhe Chen, Prof., MD,PhD
Journal: Blood
Blood (2016) 128 (22): 5840.
https://doi.org/10.1182/blood.V128.22.5840.5840
Published: 2016
Journal Articles

A 5-Day Cytoreductive Chemotherapy Followed By Haplo-Identical HSCT (FA5-Bucy) As a Tumor-Ablative Regimen Improved the Survival of Patients with Advanced Hematological Malignancies

Ting Yang, Prof., MD, PhD, Jinhua Ren, MD, Qiaoxian Lin, MD, Xiaohong Yuan, MD, Xiaofeng Luo, MD, PhD, Tingbo Liu, Prof., MD, PhD, Xiaoyun Zheng, MD, Zhizhe Chen, Prof., MD, PhD, Jianda Hu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4674.
https://doi.org/10.1182/blood.V128.22.4674.4674
Published: 2016
Journal Articles

Comparison of Outcome and Prognosis of 248 Elderly Patients with Acute Myeloid Leukemia Treated with Standard-Dose or Low-Intensity Induction Therapy

Jianda Hu, MD PhD, Yi Chen, MD, Xiaoyun Zheng, MD, Zhihong Zheng, MDPhD, Ting Yang, MDPhD, Tingbo LIU, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2540.
https://doi.org/10.1182/blood.V126.23.2540.2540
Published: 2015
Journal Articles

Life-Threatening Complications Suspected Due to Clinical Pharmacokinetic Interaction Between Cyclosporine A and Triazole Antifungal Agents in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Recipients.

Ting Yang, Danhui Fu, Jianda Hu, Xiaoyun Zheng, Xiaofeng Luo, Hongqiang Qiu, Xuemei Wu, Ruling Chen, Zhizhe Chen
Journal: Blood
Blood (2009) 114 (22): 4319.
https://doi.org/10.1182/blood.V114.22.4319.4319
Published: 2009